Featured Research

from universities, journals, and other organizations

Immunological Karma: T Cells Reactive To Old Flu Infections Make Unrelated Viral Infections Worse

Date:
November 28, 2005
Source:
Journal of Clinical Investigation
Summary:
Childhood infection with Epstein-Barr virus (EBV) is often asymptomatic, while in adolescents and adults it causes infectious mononucleosis (IM). University of Massachusetts Medical School scientists now show how, in a strange twist of immunological karma, T cells specific to a previously encountered virus (such as the flu) may come back to haunt you, by overzealously responding to a subsequent, unrelated viral infection like EBV, increasing the severity of the immune response and causing IM.

Childhood infection with Epstein-Barr virus (EBV) is often asymptomatic, while the same infection in adolescents and adults causes infectious mononucleosis (IM). Liisa Selin and colleagues from the University of Massachusetts Medical School now show how, in a strange twist of immunological karma, T cells specific to a previously encountered virus (such as the flu) may come back to haunt you, by overzealously responding to a subsequent, unrelated viral infection like EBV, thereby increasing the severity of the immune response and causing IM. Their results appear online on November 23 in advance of print publication in the December issue of the Journal of Clinical Investigation.

The authors found that, in patients with IM, memory CD8+ T cells specific to an epitope of the influenza virus encountered in a previous infection, also recognized and reacted to an epitope of the Epstein-Barr virus. These two epitopes, with only 33% similarity, stimulate different T cell activities, which in sum skew the immune response to EBV infection. Excessive lymphocyte proliferation contributes to the marked deviation in disease course and is symptomatic of IM.

Overall, this demonstration of cross-reactivity involving 2 immunodominant epitopes from 2 of the most common human viruses highlights the potential importance of cross-reactive T cells in human disease states.

###

Title: Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis

View the PDF of this article at: https://www.the-jci.org/artice.php?id=25078


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Immunological Karma: T Cells Reactive To Old Flu Infections Make Unrelated Viral Infections Worse." ScienceDaily. ScienceDaily, 28 November 2005. <www.sciencedaily.com/releases/2005/11/051125105751.htm>.
Journal of Clinical Investigation. (2005, November 28). Immunological Karma: T Cells Reactive To Old Flu Infections Make Unrelated Viral Infections Worse. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/11/051125105751.htm
Journal of Clinical Investigation. "Immunological Karma: T Cells Reactive To Old Flu Infections Make Unrelated Viral Infections Worse." ScienceDaily. www.sciencedaily.com/releases/2005/11/051125105751.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins